Common use of CONTRACT COMPONENTS Clause in Contracts

CONTRACT COMPONENTS. 14.1 The following documents constitute integral components of the Funding Contract: · the grant application (“Development of innovative cancer immunotherapies based on Hookipa’s Vaxwave® technology”) received via eCall in the version from 10/01/2014 · General Funding Conditions for Funding Contracts as amended (version 1 from 2013) · Guide for Individual Projects of Experimental Development, version 2.0 · Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.4 14.2 The legal bases of this Funding Contract are, in particular: · The Austrian Research Promotion Agency Establishment Act (Forschungsförderungs-Strukturreformgesetz, Research Funding Structural Reform Law) as amended · the guidelines for the Austrian Research Promotion Agency FFG to promote research, technology, development, and innovation (FFG Guidelines no: BMVIT-609.986/0005-111/12/2008 and BMWA-98.310/0032-C1/10/2008) The extension to 06/30/2014 was approved by the European Commission on 01/30/2014. The validity of the guidelines was extended until 12/31/2014 by the Federal Minister of Transport, Innovation and Technology on 03/12/2014 (No. BMVIT-609.986/0004-111/12/2014) i.e. by the Federal Minister of Science, Research and the Economy on 06/04/2014 (No. BMWFJ-98.310/0101-C1/10/2013) in accordance with the State aid regulations applicable as of 07/01/2014. The Funding Recipient confirms knowledge of all contract components and fully accepts them. It should be noted that the present grant offer is deemed to be withdrawn unless the Funding Recipient returns it to FFG signed within 3 months. /s/ Dr. Xxxxxxxxx Egerth-Stadlhuber /s/ Xx. Xxxxx Pseiner Dr. Xxxxxxxxx Egerth-Stadlhuber, Xx. Xxxxx Pseiner Managing Director Managing Director Vienna, Dec. 16. 2014 /s/ XX. XXXXXXXXX XXXXX XX. XXXXXXXXX XXXXX, CEO Appendix: Guidelines for the Austrian Research Promotion Agency FFG to promote research, technology, development, and innovation (FFG Guidelines) via link xxxx://xxx.xxx.xx/Allgemeine-Richtlinien General Funding Conditions for Funding Contracts as amended (version 1 from 2013) Guide for Individual Projects of Experimental Development, version 2.0 Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.4

CONTRACT COMPONENTS. 14.1 The following documents constitute integral components of the Funding Contract: · the grant application (“Development of innovative cancer immunotherapies based on Hookipa’s Vaxwave® technology”) received via eCall in the version from 10/01/2014 · General Funding Conditions for Funding Contracts as amended (version 1 from 2013) · Guide for Individual Projects of Experimental Development, version 2.0 · Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.4 14.2 The legal bases of this Funding Contract are, in particular: · The Austrian Research Promotion Agency Establishment Act (Forschungsförderungs-Strukturreformgesetz, Research Funding Structural Reform Law) as amended · the guidelines for the Austrian Research Promotion Agency FFG to promote research, technology, development, and innovation (FFG Guidelines guidelines no: BMVIT-609.986/0005-111/12/2008 and BMWA-98.310/0032-C1/10/2008) The extension to 06/30/2014 was approved by the European Commission on 01/30/2014. The validity of the guidelines was extended until 12/31/2014 by the Federal Minister of Transport, Innovation and Technology on 03/12/2014 (No. BMVIT-609.986/0004-111/12/2014) i.e. by the Federal Minister of Science, Research and the Economy on 06/04/2014 (No. BMWFJ-98.310/0101-C1/10/2013) in accordance with the State aid regulations applicable as of 07/01/2014. The Funding Recipient confirms knowledge of all contract components and fully accepts them. It should be noted that the present grant offer is deemed to be withdrawn unless the Funding Recipient returns it to FFG signed within 3 months. Vienna, 12/09/2014 /s/ Dr. Xxxxxxxxx Egerth-Stadlhuber /s/ Xx. Xxxxx Pseiner Dr. Xxxxxxxxx Egerth-Stadlhuber, Xx. Xxxxx Pseiner Managing Director Managing Director Vienna, Dec. 16. 2014 /s/ XX. XXXXXXXXX XXXXX XX. XXXXXXXXX XXXXX, CEO Appendix: Guidelines for the Austrian Research Promotion Agency FFG to promote research, technology, development, and innovation (FFG Guidelines) via link xxxx://xxx.xxx.xx/Allgemeine-Richtlinien General Funding Conditions for Funding Contracts as amended (version 1 from 2013) Guide for Individual Projects of Experimental Development, version 2.0 Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.4

CONTRACT COMPONENTS. 14.1 The following documents constitute integral components of the Funding Contract: · the  The grant application (“Development Demonstration of innovative cancer immunotherapies based on the applicability of Hookipa’s Vaxwave® technologyarenaviral vector technologies for cancer immunotherapy development”) received submitted via eCall in the version from 10/01/2014 · 12/21/2017  General Funding Conditions for Funding Contracts as amended (version 1 from 20132015) ·  Guide for Individual Projects of Experimental Development, version 2.0 · 3.3  Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.42.1 14.2 The legal bases of this Funding Contract are, in particular: ·  The Austrian Research Promotion Agency Establishment Act (Forschungsförderungs-Strukturreformgesetz, Research Funding Structural Reform Law) as amended ·  Union framework for State aid for research, development and innovation (Official Journal C 198 from 06/27/2014)  Commission Regulation (EU) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the guidelines internal market in application of Articles 107 and 108 of the Treaty on the functioning of the European Union (TFEU 2014).  Guideline for the Austrian Research Promotion Agency FFG to promote the applied research, technology, development, and innovation (FFG Guidelines Guideline for SMEs no: BMVIT-609.986/0005BMVIT-609.986/0012-111/12/2008 111/12/2014 and BMWA-98.310/0032BMWFW-98.310/0102-C1/10/2008) The extension to 06/30/2014 was approved by C1/10/2014)—These Guidelines were filed for exemption with the European Commission on 01/30/2014. The validity the basis of the guidelines was extended until 12/31/2014 by the Federal Minister of Transport, Innovation and Technology on 03/12/2014 (No. BMVIT-609.986/0004-111/12/2014) i.e. by the Federal Minister of Science, Research and the Economy on 06/04/2014 (No. BMWFJ-98.310/0101-C1/10/2013) in accordance with the State aid regulations applicable as of 07/01/2014TFEU 2014. The Funding Recipient confirms knowledge of all contract components and fully accepts themthem and notes that non-compliance with the above contractual provisions may lead to the funds being reclaimed. It should be noted The Funding Recipient confirms that no open reclaim order by the European Commission exists and that rescission, if any, of an incompatible funding is completed. The Funding Recipient agrees that the present data listed in Art. 9(1) of the TFEU (EU Regulation No. 651/2014) Appendix III may be used to publish the information if the cash value of the grant offer is deemed to be withdrawn unless the Funding Recipient returns it to FFG signed within 3 months(gross subsidy equivalent) exceeds €500,000. Vienna, 02/12/2018 /s/ Dr. Xxxxxxxxx Egerth-Stadlhuber /s/ Xx. Xxxxx Pseiner Dr. Xxxxxxxxx Egerth-Stadlhuber, Stadlhuber Xx. Xxxxx Pseiner Managing Director Managing Director Vienna, Dec. 16. 2014 02/27/2018 /s/ XX. XXXXXXXXX XXXXX XX. XXXXXXXXX XXXXXXXXXXXXX XXXXXXX XXXXXXXX XXXXXXX, CEO CFO Appendix: Guidelines Guideline for the Austrian Research Promotion Agency FFG to promote the applied research, technology, development, and innovation (FFG GuidelinesGuideline for SMEs) via link xxxx://xxx.xxx.xx/Allgemeine-Richtlinien xxxxx://xxx.xxx.xx/recht-finanzen/rechtsgrundlagen General Funding Conditions for Funding Contracts as amended (version 1 from 20132015) Guide for Individual Projects of Experimental Development, version 2.0 3.3 Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to 2.1 HOOIKIPA Biotech Gmbh attn Xx Xxxx Xxxxxxxxx-Strasser Xxxxxx-Xxxxxxxxxx-Xxxxx 0 0000 Xxxxxx AIP DW – 1206 Vienna, 25 October 2019 Project 865401, 857224, 850420, 849137, 844309, 836998 Dear Xx Xxxxxxxxx-Xxxxxxxx, During the FTE Guidelines and meeting of 23 October 2019, the Advisory Board of the FFG Guidelines, version 1.4Basic Programmes discussed your application of 26 September to waive the reclamation of the subsidies paid out for the above-mentioned projects and approved your application under the following conditions: A) Postponement of the repayment dates as proposed in your application: - Project 836998: early repayment by 31.12.2019 in the amount of € 752,168.00 - Project 844309: early repayment by 31.03.2020 in the amount of € 1,140,021.00 - Project 857224: early repayment of 50% of the loan by 30.06.2023 in the amount of € 1,059,900.00 and repayment by 31.03.2024 in the amount of € 1,059,941.00. B) Letter of intent (as proposed) from Hookipa lnc. regarding the liabilities of Hookipa Biotech GmbH to FFG C) Guarantee of employment of at least the present number (76 employees) until at least 31.03.2024 D) Guarantee of location including operational activities until at least 31.03.2024

CONTRACT COMPONENTS. 14.1 The following documents constitute integral components of the Funding Contract: · the  The grant application (“Development Demonstration of innovative cancer immunotherapies based on the applicability of Hookipa’s Vaxwave® technologyarenaviral vector technologies for cancer immunotherapy development”) received submitted via eCall in the version from 10/01/2014 · 07/07/2016.  General Funding Conditions for Funding Contracts as amended (version 1 from 20132015) ·  Guide for Individual Projects of Experimental Development, version 2.0 · 3.1  Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.42.0 14.2 The legal bases of this Funding Contract are, in particular: ·  The Austrian Research Promotion Agency Establishment Act (Forschungsförderungs-Strukturreformgesetz, Research Funding Structural Reform Law) as amended ·  Union framework for State aid for research, development and innovation (Official Journal C 198 from 06/27/2014)  Commission Regulation (EU) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the guidelines internal market in application of Articles 107 and 108 of the Treaty on the functioning of the European Union (TFEU 2014).  Guideline for the Austrian Research Promotion Agency FFG to promote the applied research, technology, development, and innovation (FFG Guidelines Guideline for SMEs no: BMVIT-609.986/0005BMVIT-609.986/0012-111/12/2008 111/12/2014 and BMWA-98.310/0032BMWFW-98.310/0102-C1/10/2008) The extension to 06/30/2014 was approved by C1/10/2014)—These Guidelines were filed for exemption with the European Commission on 01/30/2014. The validity the basis of the guidelines was extended until 12/31/2014 by the Federal Minister of Transport, Innovation and Technology on 03/12/2014 (No. BMVIT-609.986/0004-111/12/2014) i.e. by the Federal Minister of Science, Research and the Economy on 06/04/2014 (No. BMWFJ-98.310/0101-C1/10/2013) in accordance with the State aid regulations applicable as of 07/01/2014TFEU 2014. The Funding Recipient confirms knowledge of all contract components and fully accepts themthem and notes that non-compliance with the above contractual provisions may lead to the funds being reclaimed. It should be noted The Funding Recipient confirms that no open reclaim order by the European Commission exists and that rescission, if any, of an incompatible funding is completed. The Funding Recipient agrees that the present data listed in Art. 9(1) of the TFEU (EU Regulation No. 651/2014) Appendix III may be used to publish the information if the cash value of the grant offer is deemed to be withdrawn unless (gross subsidy equivalent) exceeds €500,000. For the Funding Recipient returns it to FFG signed within 3 months. Agency: The Austrian Research Promotion Agency (FFG) Vienna, 09/15/2016 /s/ Dr. Xxxxxxxxx Egerth-Stadlhuber /s/ Xx. Xxxxx Pseiner Dr. Xxxxxxxxx Egerth-Stadlhuber, Stadlhuber Xx. Xxxxx Pseiner Managing Director Managing Director Vienna, Dec. 16. 2014 10/04/2016 /s/ XX. XXXXXXXXX XXXX XXXXX XX. XXXXXXXXX XXXX XXXXX, CEO Appendix: Guidelines Guideline for the Austrian Research Promotion Agency FFG to promote the applied research, technology, development, and innovation (FFG GuidelinesGuideline for SMEs) via link xxxx://xxx.xxx.xx/Allgemeine-Richtlinien xxxxx://xxx.xxx.xx/recht-finanzen/rechtsgrundlagen General Funding Conditions for Funding Contracts as amended (version 1 from 20132015) Guide for Individual Projects of Experimental Development, version 2.0 3.1 Cost Guideline to treating version 2.0 1 Granting funds 1.1 On the basis of the grant application “Demonstration of the applicability of Hookipa’s arenaviral vector technologies for cancer immunotherapy development,” which was received via eCall on 09/29/2017, and on the basis of the expert decision of the advisory board in the 01/31/2018 meeting, funding will be granted for the following project: Project number: 865401 eCall number: 14249646 Pre-project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelinesno: 857224 Project name (subject-matter of Contract): Program: General Program Österreichische Tel +43 (0)5 7755 — 0 UniCredit Bank Austria AG Forschungsförderungsgesellschaft mbH Fax +43 (0)5 7755 — 97900 Account no. 10216727200, version 1.4Routing no. 12000 Xxxxxxxxxxx 0 xxx.xxx.xx, xxxxxx@xxx.xx IBAN XX00 0000 0000 0000 0000 1090 Vienna FH 000000x Xxxxxxxxxx Xxxxx Xxxxxx SWIFT XXXXXXXX

CONTRACT COMPONENTS. 14.1 The following documents constitute integral components of the Funding Contract: · the The grant application submitted via eCall (“Development Validation of a novel vector-based vaccine platform (Vaxwave) and development of an innovative cancer immunotherapies based on Hookipa’s Vaxwave® technologyvaccine against CMV”) received via eCall in the version from 10/01/2014 06/20/2012. · General Funding Conditions for Funding Contracts as amended (version 1 from 20131/26/2009) · FFG General Programs Guide for Individual Projects of Experimental Development, version 2.0 as amended (03/22/2012) · Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.41.3 14.2 The legal bases of this Funding Contract are, in particular: · The Austrian Research Promotion Agency Establishment Act (Forschungsförderungs-Strukturreformgesetz, Research Funding Structural Reform Law) as amended · the guidelines for the Austrian Research Promotion Agency FFG to promote research, technology, development, and innovation (FFG Guidelines no: BMVIT-609.986/0005-111/12/2008 and BMWA-98.310/0032-C1/10/2008) The extension to 06/30/2014 was approved by the European Commission on 01/30/2014. The validity of the guidelines was extended until 12/31/2014 by the Federal Minister of Transport, Innovation and Technology on 03/12/2014 (No. BMVIT-609.986/0004-111/12/2014) i.e. by the Federal Minister of Science, Research and the Economy on 06/04/2014 (No. BMWFJ-98.310/0101-C1/10/2013) in accordance with the State aid regulations applicable as of 07/01/2014. The Funding Recipient confirms knowledge of all contract components and fully accepts them. It should be noted that the present grant offer is deemed to be withdrawn unless the Funding Recipient returns it to FFG signed within 3 months. Vienna, 07/02/2012 /s/ Dr. Xxxxxxxxx Egerth-Stadlhuber /s/ Xx. Xxxxx Pseiner Dr. Xxxxxxxxx Egerth-Stadlhuber, Stadlhuber Xx. Xxxxx Pseiner Managing Director Managing Director Vienna08/08/2012, Dec. 16. 2014 Vienna /s/ XX. XXXXXXXXX XXXXX XX. XXXXXXXXX XXXXX, CEO Xxxxxxxxx Xxxxx Appendix: Guidelines for the Austrian Research Promotion Agency FFG to promote research, technology, development, and innovation (FFG Guidelines) via link xxxx://xxx.xxx.xx/Allgemeine-Richtlinien xxxx://xxx.xxx.xx/content/foerderrichtlinien General Funding Conditions for Funding Contracts as amended (version 1 from 20131/26/2009) FFG General Programs Guide for Individual Projects of Experimental Development, version 2.0 as amended (03/22/2012) Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.41.3

CONTRACT COMPONENTS. 14.1 The following documents constitute integral components of the Funding Contract: · the The grant application (“Development Demonstration of innovative cancer immunotherapies based on the applicability of Hookipa’s Vaxwave® technologyarenaviral vector technologies for cancer immunotherapy development”) received submitted via eCall in the version from 10/01/2014 07/07/2016. · General Funding Conditions for Funding Contracts as amended (version 1 from 20132015) · Guide for Individual Projects of Experimental Development, version 2.0 3.1 · Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.42.0 14.2 The legal bases of this Funding Contract are, in particular: · The Austrian Research Promotion Agency Establishment Act (Forschungsförderungs-Strukturreformgesetz, Research Funding Structural Reform Law) as amended · Union framework for State aid for research, development and innovation (Official Journal C 198 from 06/27/2014) · Commission Regulation (EU) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the guidelines internal market in application of Articles 107 and 108 of the Treaty on the functioning of the European Union (TFEU 2014). · Guideline for the Austrian Research Promotion Agency FFG to promote the applied research, technology, development, and innovation (FFG Guidelines Guideline for SMEs no: BMVIT-609.986/0005BMVIT-609.986/0012-111/12/2008 111/12/2014 and BMWA-98.310/0032BMWFW-98.310/0102-C1/10/2008) The extension to 06/30/2014 was approved by C1/10/2014)—These Guidelines were filed for exemption with the European Commission on 01/30/2014. The validity the basis of the guidelines was extended until 12/31/2014 by the Federal Minister of Transport, Innovation and Technology on 03/12/2014 (No. BMVIT-609.986/0004-111/12/2014) i.e. by the Federal Minister of Science, Research and the Economy on 06/04/2014 (No. BMWFJ-98.310/0101-C1/10/2013) in accordance with the State aid regulations applicable as of 07/01/2014TFEU 2014. The Funding Recipient confirms knowledge of all contract components and fully accepts themthem and notes that non-compliance with the above contractual provisions may lead to the funds being reclaimed. It should be noted The Funding Recipient confirms that no open reclaim order by the European Commission exists and that rescission, if any, of an incompatible funding is completed. The Funding Recipient agrees that the present data listed in Art. 9(1) of the TFEU (EU Regulation No. 651/2014) Appendix III may be used to publish the information if the cash value of the grant offer is deemed to be withdrawn unless (gross subsidy equivalent) exceeds €500,000. For the Funding Recipient returns it to FFG signed within 3 months. Agency: The Austrian Research Promotion Agency (FFG) Vienna, 09/15/2016 /s/ Dr. Xxxxxxxxx Egerth-Stadlhuber /s/ Xx. Xxxxx Pseiner Dr. Xxxxxxxxx Egerth-Stadlhuber, Stadlhuber Xx. Xxxxx Pseiner Managing Director Managing Director Vienna, Dec. 16. 2014 10/04/2016 /s/ XX. XXXXXXXXX XXXX XXXXX XX. XXXXXXXXX XXXX XXXXX, CEO Appendix: Guidelines Guideline for the Austrian Research Promotion Agency FFG to promote the applied research, technology, development, and innovation (FFG GuidelinesGuideline for SMEs) via link xxxx://xxx.xxx.xx/Allgemeine-Richtlinien xxxxx://xxx.xxx.xx/recht-finanzen/rechtsgrundlagen General Funding Conditions for Funding Contracts as amended (version 1 from 20132015) Guide for Individual Projects of Experimental Development, version 2.0 3.1 Cost Guideline to treating version 2.0 1 Granting funds 1.1 On the basis of the grant application “Demonstration of the applicability of Hookipa’s arenaviral vector technologies for cancer immunotherapy development,” which was received via eCall on 09/29/2017, and on the basis of the expert decision of the advisory board in the 01/31/2018 meeting, funding will be granted for the following project: Project number: 865401 eCall number: 14249646 Pre-project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelinesno: 857224 Project name (subject-matter of Contract): Program: General Program Österreichische Tel +43 (0)5 7755 — 0 UniCredit Bank Austria AG Forschungsförderungsgesellschaft mbH Fax +43 (0)5 7755 — 97900 Account no. 10216727200, version 1.4Routing no. 12000 Xxxxxxxxxxx 0 xxx.xxx.xx, xxxxxx@xxx.xx IBAN XX00 0000 0000 0000 0000 1090 Vienna FH 000000x Xxxxxxxxxx Xxxxx Xxxxxx SWIFT XXXXXXXX

CONTRACT COMPONENTS. 14.1 The following documents constitute integral components of the Funding Contract: · the The grant application submitted via eCall (“Development Validation of a novel vector-based vaccine platform (Vaxwave) and development of an innovative cancer immunotherapies based on Hookipa’s Vaxwave® technologyvaccine against CMV”) received via eCall in the version from 10/01/2014 10/30/2013. · General Funding Conditions for Funding Contracts as amended (version 1 from 2013) · FFG General Programs Guide for Individual Projects of Experimental Development, version 2.0 as amended (03/22/2012) · Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.41.3 14.2 The legal bases of this Funding Contract are, in particular: · The Austrian Research Promotion Agency Establishment Act (Forschungsförderungs-Strukturreformgesetz, Research Funding Structural Reform Law) as amended · the guidelines for the Austrian Research Promotion Agency FFG to promote research, technology, development, and innovation (FFG Guidelines no: BMVIT-609.986/0005-111/12/2008 111/12/ 2008 and BMWA-98.310/0032-C1/10/2008C1/10/ 2008) The extension to 06/30/2014 was approved by the European Commission on 01/30/2014. The validity of the guidelines was extended until 12/31/2014 by the Federal Minister of Transport, Innovation and Technology on 03/12/2014 (No. BMVIT-609.986/0004-111/12/2014) i.e. by the Federal Minister of Science, Research and the Economy on 06/04/2014 (No. BMWFJ-98.310/0101-C1/10/2013) in accordance with the State aid regulations applicable as of 07/01/2014. The Funding Recipient confirms knowledge of all contract components and fully accepts them. It should be noted that the present grant offer is deemed to be withdrawn unless the Funding Recipient returns it to FFG signed within 3 months. Vienna, 12/06/2013 /s/ Dr. Xxxxxxxxx Egerth-Stadlhuber /s/ Xx. Xxxxx Pseiner Dr. Xxxxxxxxx Egerth-Stadlhuber, Xx. Xxxxx Pseiner Managing Director Managing Director Vienna, on Dec. 16. 2014 17 2013 /s/ XX. XXXXXXXXX XXXXX XX. XXXXXXXXX XXXXX, CEO Appendix: Guidelines for the Austrian Research Promotion Agency FFG to promote research, technology, development, and innovation (FFG Guidelines) via link xxxx://xxx.xxx.xx/Allgemeine-Richtlinien General Funding Conditions for Funding Contracts as amended (version 1 from 2013) FFG General Programs Guide for Individual Projects of Experimental Development, version 2.0 as amended (03/22/2012) Cost Guideline to treating project costs in grant applications and reports for projects with grant agreements according to the FTE Guidelines and the FFG Guidelines, version 1.41.3